Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 02 08 2022
accepted: 05 10 2022
entrez: 7 11 2022
pubmed: 8 11 2022
medline: 9 11 2022
Statut: epublish

Résumé

To safely resume in-person activities during the COVID-19 pandemic, Sapienza University of Rome implemented rigorous infection prevention and control measures, a successful communication campaign and a free SARS-CoV-2 testing program. In this study, we describe the University's experience in carrying out such a program in the context of the COVID-19 response and identify risk factors for infection. Having identified resources, space, supplies and staff, from March to June 2021 Sapienza offered to all its enrollees a molecular test service (8.30 AM to 4 PM, Monday to Thursday). A test-negative case-control study was conducted within the program. Participants underwent structured interviews that investigated activity-related exposures in the 2 weeks before testing. Multivariable conditional logistic regression analyses were performed. Adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) were calculated. A total of 8,959 tests were administered, of which 56 were positive. The detection trend followed regional tendencies. Among 40 cases and 80 controls, multivariable analysis showed that a known exposure to a COVID-19 case increased the likelihood of infection (aOR: 8.39, 95% CI: 2.38-29.54), while having a job decreased it (aOR: 0.23, 95% CI: 0.06-0.88). Of factors that almost reached statistical significance, participation in activities in the university tended to reduce the risk (aOR: 0.32, 95% CI: 0.09-1.06), while attendance at private gatherings showed an increasing risk trend (aOR: 3.48, 95% CI: 0.95-12.79). Age, gender, activities in the community, visiting bars or restaurants, and use of public transportation were not relevant risk factors. When those students regularly attending the university campus were excluded from the analysis, the results were comparable, except that attending activities in the community came close to having a statistically significant effect (aOR: 8.13, 95% CI: 0.91-72.84). The testing program helped create a safe university environment. Furthermore, promoting preventive behavior and implementing rigorous measures in public places, as was the case in the university setting, contributed to limit the virus transmission.

Sections du résumé

Background
To safely resume in-person activities during the COVID-19 pandemic, Sapienza University of Rome implemented rigorous infection prevention and control measures, a successful communication campaign and a free SARS-CoV-2 testing program. In this study, we describe the University's experience in carrying out such a program in the context of the COVID-19 response and identify risk factors for infection.
Methods
Having identified resources, space, supplies and staff, from March to June 2021 Sapienza offered to all its enrollees a molecular test service (8.30 AM to 4 PM, Monday to Thursday). A test-negative case-control study was conducted within the program. Participants underwent structured interviews that investigated activity-related exposures in the 2 weeks before testing. Multivariable conditional logistic regression analyses were performed. Adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) were calculated.
Results
A total of 8,959 tests were administered, of which 56 were positive. The detection trend followed regional tendencies. Among 40 cases and 80 controls, multivariable analysis showed that a known exposure to a COVID-19 case increased the likelihood of infection (aOR: 8.39, 95% CI: 2.38-29.54), while having a job decreased it (aOR: 0.23, 95% CI: 0.06-0.88). Of factors that almost reached statistical significance, participation in activities in the university tended to reduce the risk (aOR: 0.32, 95% CI: 0.09-1.06), while attendance at private gatherings showed an increasing risk trend (aOR: 3.48, 95% CI: 0.95-12.79). Age, gender, activities in the community, visiting bars or restaurants, and use of public transportation were not relevant risk factors. When those students regularly attending the university campus were excluded from the analysis, the results were comparable, except that attending activities in the community came close to having a statistically significant effect (aOR: 8.13, 95% CI: 0.91-72.84).
Conclusions
The testing program helped create a safe university environment. Furthermore, promoting preventive behavior and implementing rigorous measures in public places, as was the case in the university setting, contributed to limit the virus transmission.

Identifiants

pubmed: 36339150
doi: 10.3389/fpubh.2022.1010130
pmc: PMC9627192
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1010130

Investigateurs

Federica Maria Di Lella (F)
Sofia Di Virgilio (S)
Pierluigi Donia (P)
Emiliano Rapiti (E)
Donatella Maria Rodio (D)
Geltrude Taddeo (G)

Informations de copyright

Copyright © 2022 Baccolini, Siena, Renzi, Migliara, Colaprico, Romano, Massimi, Marzuillo, De Vito, Casini, Antonelli, Turriziani, Angeloni, D'Alba, Villari, Polimeni and Collaborating Group.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2022 Feb 11;17(2):e0263597
pubmed: 35148359
Ann Intern Med. 2020 Oct 20;173(8):638-641
pubmed: 32614638
JAMA Intern Med. 2021 Aug 1;181(8):1090-1099
pubmed: 34152363
Int J Environ Res Public Health. 2020 Nov 24;17(23):
pubmed: 33255181
J Public Health Res. 2021 Jan 27;9(Suppl 1):1957
pubmed: 33575228
J Prof Nurs. 2021 Sep-Oct;37(5):948-953
pubmed: 34742527
Eur J Epidemiol. 2021 Feb;36(2):179-196
pubmed: 33634345
Int J Environ Res Public Health. 2021 Dec 04;18(23):
pubmed: 34886516
Nat Commun. 2021 Jul 27;12(1):4570
pubmed: 34315899
Epidemiology. 2019 Nov;30(6):838-844
pubmed: 31430265
J Occup Health. 2021 Jan;63(1):e12209
pubmed: 33665926
J Infect Dis. 2021 Feb 24;223(4):550-561
pubmed: 33249484
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
Front Public Health. 2021 Nov 04;9:772782
pubmed: 34805081
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1258-1264
pubmed: 32915165
Front Psychol. 2021 Apr 22;12:648443
pubmed: 33967909
EuroMediterr J Environ Integr. 2021;6(1):30
pubmed: 33585671
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
PLoS One. 2021 Dec 17;16(12):e0261230
pubmed: 34919584
Vaccines (Basel). 2021 Nov 07;9(11):
pubmed: 34835223
JAMA. 2021 Apr 13;325(14):1464-1465
pubmed: 33616617
BMC Public Health. 2021 Aug 6;21(1):1520
pubmed: 34362333
Front Psychol. 2021 Oct 12;12:769622
pubmed: 34712192
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33827987
J Infect Public Health. 2020 Nov;13(11):1630-1638
pubmed: 32855090
Cell Rep Med. 2022 Feb 21;3(3):100556
pubmed: 35474742
Front Psychol. 2021 Jul 14;12:692503
pubmed: 34335409
Lancet Reg Health Eur. 2021 Aug;7:100148
pubmed: 34124709
Public Health Pract (Oxf). 2022 Jun;3:100255
pubmed: 35403074
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):528-532
pubmed: 33830981
Public Health. 2022 Mar;204:70-75
pubmed: 35176623
Nat Med. 2021 Dec;27(12):2120-2126
pubmed: 34707317

Auteurs

Valentina Baccolini (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Leonardo Maria Siena (LM)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Erika Renzi (E)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Giuseppe Migliara (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Corrado Colaprico (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Alessandra Romano (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Azzurra Massimi (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Carolina Marzuillo (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Corrado De Vito (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Leandro Casini (L)

Special Office for Prevention, Protection and High Vigilance, Sapienza University of Rome, Rome, Italy.

Guido Antonelli (G)

Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Ombretta Turriziani (O)

Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Antonio Angeloni (A)

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Fabrizio D'Alba (F)

Policlinico Umberto I Teaching Hospital, Rome, Italy.

Paolo Villari (P)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Antonella Polimeni (A)

Department of Oral and Maxillofacial Science, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH